Mary Sides

Mary Sides possesses extensive experience in regulatory science and affairs, currently serving as the Executive Regulatory Science Director at AstraZeneca. Previously, Mary held multiple senior director positions at GlaxoSmithKline, which included roles as Senior Director, Director, Associate Director, and Assistant Director, as well as experience as a Submission Specialist. This diverse background reflects a strong expertise in regulatory processes within the pharmaceutical industry.